Cooper Companies Past Earnings Performance
Past criteria checks 4/6
Cooper Companies's earnings have been declining at an average annual rate of -20.2%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 9.8% per year. Cooper Companies's return on equity is 4.9%, and it has net margins of 10.1%.
Key information
-20.2%
Earnings growth rate
-20.3%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 9.8% |
Return on equity | 4.9% |
Net Margin | 10.1% |
Next Earnings Update | 06 Mar 2025 |
Recent past performance updates
Recent updates
The Returns On Capital At Cooper Companies (NASDAQ:COO) Don't Inspire Confidence
Dec 18The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings Haven't Escaped The Attention Of Investors
Dec 02We Think Cooper Companies (NASDAQ:COO) Can Stay On Top Of Its Debt
Nov 17The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Revenue & Expenses Breakdown
How Cooper Companies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Oct 24 | 3,895 | 392 | 1,532 | 155 |
31 Jul 24 | 3,804 | 359 | 1,527 | 154 |
30 Apr 24 | 3,732 | 340 | 1,521 | 152 |
31 Jan 24 | 3,666 | 291 | 1,580 | 145 |
31 Oct 23 | 3,593 | 294 | 1,530 | 137 |
31 Jul 23 | 3,514 | 275 | 1,488 | 130 |
30 Apr 23 | 3,427 | 288 | 1,467 | 122 |
31 Jan 23 | 3,380 | 375 | 1,350 | 116 |
31 Oct 22 | 3,308 | 386 | 1,344 | 110 |
31 Jul 22 | 3,219 | 431 | 1,297 | 107 |
30 Apr 22 | 3,139 | 948 | 1,238 | 103 |
31 Jan 22 | 3,029 | 939 | 1,205 | 98 |
31 Oct 21 | 2,923 | 2,945 | 1,142 | 93 |
31 Jul 21 | 2,845 | 2,916 | 1,122 | 93 |
30 Apr 21 | 2,660 | 2,355 | 1,054 | 90 |
31 Jan 21 | 2,465 | 2,249 | 997 | 93 |
31 Oct 20 | 2,431 | 238 | 991 | 93 |
31 Jul 20 | 2,441 | 278 | 937 | 91 |
30 Apr 20 | 2,542 | 343 | 972 | 91 |
31 Jan 20 | 2,672 | 454 | 981 | 88 |
31 Oct 19 | 2,653 | 467 | 993 | 87 |
31 Jul 19 | 2,613 | 446 | 981 | 86 |
30 Apr 19 | 2,594 | 427 | 957 | 87 |
31 Jan 19 | 2,571 | 366 | 944 | 87 |
31 Oct 18 | 2,533 | 140 | 973 | 85 |
31 Jul 18 | 2,443 | 128 | 907 | 81 |
30 Apr 18 | 2,339 | 131 | 864 | 76 |
31 Jan 18 | 2,230 | 175 | 823 | 72 |
31 Oct 17 | 2,139 | 373 | 799 | 69 |
31 Jul 17 | 2,096 | 345 | 756 | 68 |
30 Apr 17 | 2,055 | 329 | 739 | 67 |
31 Jan 17 | 2,016 | 298 | 726 | 67 |
31 Oct 16 | 1,967 | 274 | 711 | 65 |
31 Jul 16 | 1,904 | 250 | 679 | 63 |
30 Apr 16 | 1,851 | 207 | 666 | 64 |
31 Jan 16 | 1,801 | 194 | 656 | 64 |
31 Oct 15 | 1,797 | 204 | 661 | 65 |
31 Jul 15 | 1,810 | 198 | 659 | 67 |
30 Apr 15 | 1,780 | 241 | 655 | 66 |
31 Jan 15 | 1,758 | 259 | 648 | 66 |
31 Oct 14 | 1,718 | 270 | 639 | 66 |
31 Jul 14 | 1,661 | 296 | 632 | 64 |
30 Apr 14 | 1,640 | 297 | 623 | 63 |
31 Jan 14 | 1,611 | 293 | 618 | 61 |
Quality Earnings: COO has high quality earnings.
Growing Profit Margin: COO's current net profit margins (10.1%) are higher than last year (8.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: COO's earnings have declined by 20.2% per year over the past 5 years.
Accelerating Growth: COO's earnings growth over the past year (33.3%) exceeds its 5-year average (-20.2% per year).
Earnings vs Industry: COO earnings growth over the past year (33.3%) exceeded the Medical Equipment industry 12.9%.
Return on Equity
High ROE: COO's Return on Equity (4.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 04:17 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/10/31 |
Annual Earnings | 2024/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Cooper Companies, Inc. is covered by 34 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jeffrey Johnson | Baird |
Ishan Majumdar | Baptista Research |
Joanne Wuensch | BMO Capital Markets Equity Research |